Internet CBT for Depression in Older ICU Survivors
This study, called ADEPT-ICU, is looking at whether an internet-based therapy called Good Days Ahead (MindStreet, Inc.) can help older adults who have been in the intensive care unit (ICU) and are experiencing depression. Depression after an ICU stay can sometimes lead to problems with memory and thinking (cognitive decline). The study aims to see if this therapy can reduce these memory and thinking issues. You might be able to join if you are 50 or older, spent more than 48 hours in the ICU, and have symptoms of depression. The main goal is to see how your subjective cognitive decline (your own feeling of decline in memory and thinking) changes over 6 and 12 months.
- Study design
- This study plans to enroll 300 participants. It compares two groups: one receiving therapist-assisted internet cognitive-behavioral therapy and another receiving depression education and standard care.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months and 12 months to check for changes in subjective cognitive decline.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Attenuating DEPression With Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)
At a glance
Conditions
NCT06627894
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Eskenazi Hospital
Indianapolis, Indianastudy coordinator listed
Recruiting
IU Health Methodist Hospital
Indianapolis, Indianastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Babar Khan, MD, MS · PRINCIPAL_INVESTIGATOR · Indiana University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Subjective Cognitive DeclineMeasured at 6-month and 12-month follow-up.
The primary outcome will be subjective cognitive decline (SCD), measured using the Cognitive Change Index self-report version (CCI-SR).